1Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient.A call for new definition and risk assessment strategies:part Ⅰ and part Ⅱ[J].Circulation,2003,108(15):1772-1778.
2Patel NA,Stamper DL,Brezinski ME.Review of the ability of optical coherence tomography to characterize plaque,including a comparison with intravascular ultrasound[J].Cardiovasc Intervent Radiol,2005,28(1):1-9.
3Brezinski ME,Tearney GJ,Bouma BE,et al.Optical coherence tomography for optical biopsy properties and demonstration of vascular pathology[J].Circulation,1996,93(6):1206.
4Yabushita H,Bouma BE,Houser SL,et al.Characterization of human atherosclerosis by optical coherence tomography[J].Circulation,2002,106(3):1640-1645.
5de Korte CL,Carlier SG,Mastik F,et al.Morphological and mechanical information of coronary arteries obtained with intravascular elastography:Feasibility study in vivo[J].Eur Heart J,2002,23(5):405-413.
6Tearney GJ,Yabushita H,Houser SL,et al.Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography[J].Circulation,2003,107(22):e212.
7Fujimoto JG,Boppart SA,Tearney GJ,et al.High resolution in vivo intra-arterial imaging with optial coherence tomography[J].Heart,1999,82(2):128-33.
8MacNeill BD,Jang IK,Bouma BE,et al.Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease[J].J Am Coll Cardiol,2004,44(5):972-979.
9Jang IK,Tearney GJ,MacNeill B,et al.In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography[J].Circulation,2005,111(12):1551-1555.
10Brezinski ME,Tearney GJ,Weissman NJ,et al.Assessing atherosclerotic plaque morphology:comparison of optical coherence tomography and high frequency intravascular ultrasound[J].Heart,1997,77(5):397-403.
